Rani Therapeutics Holdings RANI Cash Flow Statement (2020-2026)

NASDAQ RANI
$0.57 +0.01 (+1.41%)
At close: Nov 11, 2026 · 4:00 PM EST
Reported Financials

Rani Therapeutics Holdings Quarterly Cash Flow Statement

Periods 26 quarters
Latest Sep 2026

Rani Therapeutics Holdings reported cash from operations of -$7.78M and free cash flow of -$7.96M for the quarter ended Sep 2026, down 53.6% year over year. This cash flow statement covers 26 quarters of results from Jun 2020 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Operating Activities
Net Income
-13.31M-13.83M-15.97M-16.21M-17.34M-16.83M-18.66M-18.33M-14.06M-14.78M-13.36M-12.72M-15.72M-12.74M-11.22M-7.91M-9.12M-8.02M-8.42M-8.81M
Depreciation and DepletionDep. & Depletion
0.12M0.11M0.12M0.14M0.13M0.30M0.20M0.20M0.20M0.20M0.20M0.10M
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges
0.02M0.06M0.06M0.06M0.06M0.06M0.06M0.06M0.06M0.06M0.06M0.06M0.06M0.03M
Depreciation & Amortization (CF)Dep. & Amort.
0.11M0.11M0.12M0.14M0.17M0.19M0.19M0.22M0.23M0.25M0.26M0.26M0.27M0.25M0.24M0.22M0.19M0.16M0.15M0.12M
Share-based CompensationStock Comp.
3.16M2.91M3.98M4.40M4.50M4.42M5.14M4.97M4.49M3.87M4.13M4.04M3.99M3.93M3.29M2.34M2.24M2.08M2.42M2.22M
Gains from Investment SecuritiesGains Investment
-0.01M-0.01M-0.03M-0.03M
Other non-cash itemsOther Non-Cash
-1.40M0.16M0.24M0.26M0.26M0.26M0.26M0.38M0.10M0.86M0.48M0.48M0.48M0.02M1.04M0.48M0.48M0.56M
Change in Working Capital
Change in ReceivablesChange Receivables
0.60M-1.03M2.47M
Change in Account PayablesChange Payables
-0.13M0.08M0.13M0.17M-0.21M0.08M-0.41M0.40M-0.66M0.16M-0.30M1.06M-0.21M0.16M0.28M0.67M-2.16M0.55M-0.20M-0.26M
Change in Accrued ExpensesChange Accrued Exp.
-1.61M0.65M0.80M0.94M-1.79M0.32M1.38M-0.08M-2.17M0.88M-0.20M-0.63M0.29M0.17M0.39M-0.55M3.18M0.76M-1.57M0.96M
Change in Other Operating AssetsOther Assets Change
-0.48M-0.72M-0.61M1.45M-0.62M-0.32M-0.54M0.93M-0.35M-0.50M-0.68M0.83M0.14M-0.78M0.00M-0.52M1.06M0.09M-0.57M0.14M
Change in Other Operating LiabilitiesOther Liabilities Change
-0.16M-0.16M-0.21M-0.24M-0.26M-0.26M-0.26M-0.26M-0.38M-0.10M-0.26M-1.08M-0.48M-0.48M-0.47M8.06M-2.19M-2.19M-2.18M
Other Working Capital ChangesOther WC Changes
0.48M0.56M0.45M-1.66M0.39M0.06M0.28M-1.19M0.09M0.12M0.58M-1.09M-1.21M0.30M-0.48M0.05M7.00M-2.27M-1.62M-2.32M
Other Operating Activities (as filed)
0.00M
Cash from OperationsCash from Ops.
-11.45M-9.36M-10.33M-12.20M-14.63M-12.15M-12.30M-14.30M-12.48M-9.40M-9.03M-8.41M-8.66M-8.15M-5.80M-5.06M0.29M-6.50M-9.02M-7.78M
Investing Activities
Capital ExpendituresCapex
0.27M0.25M0.38M0.46M0.53M0.25M0.34M0.48M0.17M0.02M0.09M0.13M0.03M0.05M0.04M0.02M0.03M0.18M
Change in Property, Plant and EquipmentChange in PP&E
-0.27M-0.25M-0.38M-0.46M-0.53M-0.25M-0.34M-0.48M-0.17M-0.02M-0.09M-0.13M-0.03M-0.05M-0.04M-0.02M-0.03M-0.18M
Purchase of InvestmentsInvestments Purchased
70.89M2.93M18.63M33.88M11.35M9.41M10.04M11.58M18.11M17.75M2.72M30.97M23.44M34.48M15.05M
Sale and Maturity of InvestmentsInvestments Sold
3.00M23.00M35.00M23.50M22.85M55.85M18.20M18.70M20.30M45.88M5.75M21.00M19.95M22.09M
Cash from Investing ActivitiesCash from Investing
-0.27M-0.25M-0.38M-71.35M-0.46M4.12M0.79M11.67M13.27M10.29M6.53M0.47M2.52M18.23M5.71M-30.97M-2.45M-14.56M6.86M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
14.90M
Long-Term Debt RepaymentsLT Debt Repayment
1.25M3.75M3.75M3.75M3.75M9.47M
Net Long-Term Debt Issued (Repaid)Net LT Debt
14.90M-1.25M-3.75M-3.75M-3.75M-3.75M-9.47M
Net Debt Issuances and RepaymentsNet Debt Issuance
14.90M-1.25M-3.75M-3.75M-3.75M-3.75M-9.47M
Change in Capital Stock
Common Stock IssuedStock Issued
-0.57M0.05M0.15M0.12M0.13M0.09M0.08M0.10M0.12M0.17M8.88M0.00M0.04M3.95M-0.06M-3.84M0.01M18.82M-0.34M
Net Shares Issued and RepurchasedNet Shares Issued
-0.57M0.05M0.15M0.12M0.13M0.09M0.08M0.10M0.12M0.17M8.88M0.00M0.04M3.95M-0.06M-3.84M0.01M18.82M-0.34M
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
Net Equity Issued and RepurchasedNet Equity Issued
-0.57M0.05M0.15M0.12M0.13M0.09M0.08M0.10M0.12M0.17M8.88M0.00M0.04M3.95M-0.06M-3.84M0.01M18.82M-0.34M
Other financing activities (as filed)
-0.73M-0.15M-0.12M-0.01M-0.03M-0.02M-0.01M-0.01M-0.02M-0.01M-0.01M-0.02M-0.03M-0.01M-0.01M
Cash from Financing ActivitiesCash from Financing
-0.57M0.05M14.08M14.87M0.01M0.08M0.05M0.10M0.12M0.14M7.70M5.62M-3.73M0.19M-1.01M44.85M-0.03M18.81M-0.35M
Additional items
Change in Cash
-12.29M-9.61M-10.66M-69.46M-0.21M-8.02M-11.43M-2.58M0.89M1.01M-2.36M-0.24M-0.52M6.35M0.11M-6.07M14.17M-8.97M-4.78M-1.25M
Ending Cash Balance
117.45M107.84M97.18M27.72M27.51M19.48M8.05M5.47M6.36M7.38M5.01M4.78M4.26M10.61M10.72M4.64M18.82M9.84M5.07M3.82M
Free Cash FlowFCF
-11.72M-9.61M-10.71M-12.65M-15.16M-12.40M-12.64M-14.78M-12.65M-9.42M-9.12M-8.54M-8.69M-8.20M-5.83M-5.06M0.29M-6.52M-9.06M-7.96M
Net Cash FlowNCF
-12.29M-9.61M-10.66M-69.46M-0.21M-8.02M-11.43M-2.58M0.89M1.01M-2.36M-0.24M-0.52M6.35M0.11M-6.07M14.17M-8.98M-4.77M-1.26M
Interest Paid

Rani Therapeutics Holdings Cash Flow Statement API

Pull Rani Therapeutics Holdings's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=RANI&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY